More Imugene Ltd news Imugene LtdASX: IMU CF33 Oncolytic Virus Clinical Trial Program Update Oct 21, 2019 at 2:36 AM UTC · Issued by Imugene Ltd As issuedPlain English Imugene Ltd has released a press release. View Attachment
